A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2009
12/16/2009	CN100569244C Self emulsified soft capsule of ginkgo leaf extract and its preparing method
12/16/2009	CN100569237C Anti-respiratory virus medicine and use
12/16/2009	CN100569229C Specific recipe for killing skin fungus
12/15/2009	US7632951 Inhibitors of integrin ανβ6
12/15/2009	US7632871 Methods of making and methods of using antiseptic disinfectant, cosmetic and toiletries, medicine or food containing the same
12/15/2009	US7632828 1-Methyl, 2-((2-(2-(guanidinoethyl(dimethylammonium)ethyl-)(naphthyl-1,5-ylene)oxymethyl-),6-(1-hydroxyethyl-)carbapen-2-em-3-carboxylate; 1-methylcarbapenems as bactericides; drug resistance; multidrug resistance; methicillin-resistant Staphylococcus aureus (MRSA) and S. epidermidis(MRSE)
12/15/2009	US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system
12/15/2009	US7632516 Moraxella catarrhalis BASB115 polypeptides
12/15/2009	US7632512 Use of polynucleotides encoding small acid-soluble spore protein for inhibiting bacterial cell growth and/or treating bacterial infections
12/15/2009	US7632510 Methods of inducing flavivirus immune responses through the administration of recombinant flaviviruses comprising an engineered japanese encephalitis virus signal sequence
12/15/2009	US7632502 Immunoglobulin for diagnosis and prevention of yeast infections
12/15/2009	CA2502264C N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials
12/15/2009	CA2481078C Method and compositions for the synthesis of bch-189 and related compounds
12/15/2009	CA2399087C Use of retinoid-type compounds as antibacterial agents
12/15/2009	CA2398908C Adenosine a2a receptor antagonists for treating and preventing hepatic fibrosis, cirrhosis and fatty liver
12/15/2009	CA2388320C N-substituted carbamoyloxyalkyl-azolium derivatives
12/15/2009	CA2345138C Polymer conjugates of interferon beta-1a and their uses
12/15/2009	CA2344049C Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
12/15/2009	CA2338000C Water-soluble 4-thio-maleimido derivatives and methods for their production
12/15/2009	CA2335617C Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
12/15/2009	CA2333125C Alpha emitting constructs and uses thereof
12/10/2009	WO2009149443A2 A metal-citrate transporter antigen from streptomyces coelicolor and uses thereof
12/10/2009	WO2009149377A1 Use of pegylated type iii interferons for the treatment of hepatitis c
12/10/2009	WO2009149288A2 Extracts of cranberry and methods of using thereof
12/10/2009	WO2009149264A2 Anti-bacterial composition and method of using same
12/10/2009	WO2009149179A2 Enhanced antiviral therapy methods and devices
12/10/2009	WO2009148923A1 Hepatitis c virus inhibitors
12/10/2009	WO2009148875A1 Oral compositions containing enhanced antibacterial combinations of antioxidants and extracts of magnolia
12/10/2009	WO2009148599A1 Pyrrole compunds that modulate hsp90 activity
12/10/2009	WO2009148348A1 Method for controlling infections and tumoral diseases by suppressing multidrug resistance
12/10/2009	WO2009148294A1 Extract from the skin of rana catesbeiana, compound and method for treating mastitis in cattle
12/10/2009	WO2009148287A2 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases
12/10/2009	WO2009147980A1 Use of inactivated japanese encephalitis virus particle as adjuvant
12/10/2009	WO2009147635A1 Fulvic acid and antibiotic combination
12/10/2009	WO2009147616A1 [4-(1-amino-ethyl) -cyclohexyl] -methyl-amine and [6-(1-amino-ethyl) -tetrahydro- pyran-3-yl] -methyl-amine derivatives as antibacterials
12/10/2009	WO2009147440A1 Heterocyclic urea derivatives and methods of use thereof
12/10/2009	WO2009147433A1 Heterocyclic urea derivatives for the treatment of bacterial infections
12/10/2009	WO2009147075A2 Pharmaceutical compositions containing a crystalline form of posaconazole
12/10/2009	WO2009146902A1 A vaccine for the prevention and therapy of hcv infections
12/10/2009	WO2009146885A2 Lipidated antibacterial peptides
12/10/2009	WO2009146807A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndroms
12/10/2009	WO2009146555A1 Hiv integrase inhibitors from pyridoxine
12/10/2009	WO2009146542A1 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith
12/10/2009	WO2009123575A8 A photosensitising composition and its uses
12/10/2009	WO2009111785A3 Treatment of sepsis with 5-ethyl-1-phenyl-2(1h)-pyridone and novel methods for synthesis
12/10/2009	WO2009109860A3 Mutant forms of chlamydia htra
12/10/2009	US20090306218 Antimicrobial formulations
12/10/2009	US20090306195 Fusion Proteins of Mycobacterium Tuberculosis
12/10/2009	US20090306189 Methods for Controlling Pests Using Rnai
12/10/2009	US20090306185 Nanogenomics for medicine: siRNA engineering
12/10/2009	US20090306174 Novel Five-Membered Iminocyclitol Derivatives as Selective and Potent Glycosidase Inhibitors: New Structures for Antivirals and Osteoarthritis Therapeutics
12/10/2009	US20090306164 Methods for Treating Papilloma Virus Infection
12/10/2009	US20090306114 Polymorphic and Other Crystalline Forms of Cis-FTC
12/10/2009	US20090306099 Monitoring human response to antiviral agents; obtain tissue sample, extract nucleotide sequences, detect tumor necrosis factor genotype, presence of genotype indicates sensitivity to viricide; treating a male Caucasian human in need of treatment with abacavir
12/10/2009	US20090306095 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
12/10/2009	US20090306089 Compounds
12/10/2009	US20090306085 Hcv protease inhibitors and uses thereof
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306066 Peptide deformylase inhibitors
12/10/2009	US20090306054 Integrase inhibitors
12/10/2009	US20090306035 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest
12/10/2009	US20090306022 7-substituted tetracycline compounds
12/10/2009	US20090306021 Antimicrobial therapy for bacterial infections
12/10/2009	US20090306007 Nucleosides with antiviral and anticancer activity
12/10/2009	US20090306006 Use of nicotinic acid adenine dinucleotide phosphate or derivative thereof as agent for treating type-2 diabetes
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305953 Dalbavancin compositions for treatment of bacterial infections
12/10/2009	US20090305949 Glycosylated specificity exchanger
12/10/2009	US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009	US20090304817 Glycosylation Variants of Ricin-Like Proteins
12/10/2009	US20090304813 Virucidal compositions and uses
12/10/2009	US20090304808 Anti-cancer immune-modulating agent
12/10/2009	US20090304746 Inducing cellar immune responses to hepatitis C virus using peptide and nucleic acid compositions
12/10/2009	US20090304745 Chimeric alphavirus replicon particles
12/10/2009	US20090304743 Composition and Methods for Immunisation Using CD1D Ligands
12/10/2009	US20090304740 Use in HIV vaccines; HIV envelope proteins modified to expose the CD4 binding region
12/10/2009	US20090304729 Cell-derived viral vaccines with low levels of residual cell dna
12/10/2009	US20090304723 Mono-and disaccharide derivatives
12/10/2009	US20090304722 Chlamydia trachomatis antigens for vaccine and diagnostic use
12/10/2009	US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009	US20090304688 Methods and Compositions for Increasing the Efficiency of Therapeutic Antibodies Using Gamma Delta T Cell Activators
12/10/2009	US20090304684 Methods and compositions for needleless delivery of antibodies
12/10/2009	US20090304683 Soluble Fragments of The Sars-Cov Spike Glycoprotein
12/10/2009	US20090304658 Method of proliferating lak cell
12/10/2009	US20090304656 Controlled activation of the reuterin-production machinery of lactobacillus
12/10/2009	US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/10/2009	US20090304638 Composition for the treatment of ballast water containing bacteriophage as an effective component and biological method with the same for removing bacteria present in ballast water
12/10/2009	US20090304634 Novel Combinations
12/10/2009	US20090304633 Chimeric vaccine antigens against classical swine fever virus
12/10/2009	US20090304632 HETEROCYCLIC NF-kB INHIBITORS
12/10/2009	US20090304631 Hepatitis c serine protease inhibitors and uses therefor
12/10/2009	US20090304629 Macrocyclic hepatitis c serine protease inhibitors
12/10/2009	US20090304627 Smallpox dna vaccine and the antigens therein that elicit an immune response
12/10/2009	US20090304626 Hepatitis C Virus Inhibitors
12/10/2009	US20090304605 Substituted Aminothiazole Prodrugs of Compounds with Anti-HCV Activity
12/10/2009	DE19612966B4 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren MDCK cells and methods for the propagation of influenza virus
12/10/2009	DE102008027361A1 Composition, useful e.g. for the chemosensibilizing and simultaneous apoptosis induction of multidrug resistance of tumor cells and bacteria, comprises substituted disiloxane compound in combination with benzoxazole derivatives
12/10/2009	CA2728423A1 Respiratory syncytial virus renders dendritic cells tolerogenic
12/10/2009	CA2727026A1 Use of pegylated type iii interferons for the treatment of hepatitis c

1 ... 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 ... 1798